Nj State Employees Deferred Compensation Plan Gilead Sciences, Inc. Transaction History
Nj State Employees Deferred Compensation Plan
- $877 Million
- Q3 2025
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 10,760 shares of GILD stock, worth $1.28 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
10,760
Previous 14,000
23.14%
Holding current value
$1.28 Million
Previous $1.55 Million
23.07%
% of portfolio
0.14%
Previous 0.19%
Shares
4 transactions
Others Institutions Holding GILD
# of Institutions
2,363Shares Held
1.02BCall Options Held
12.1MPut Options Held
9.11M-
Black Rock Inc. New York, NY121MShares$14.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.1 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.03 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.5 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.46 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $149B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...